Key result
Higher CHA2DS2-VASc score is linked to ~62% greater long-term MACE risk after CABG.
Why the study?
The study was conducted to investigate the value of the CHA2DS2-VASc score in predicting long-term major cardiovascular events following coronary artery bypass grafting.
Does the CHA2DS2-VASc score predict long-term major cardiovascular events in patients undergoing elective coronary artery bypass grafting?
Cohort (n=559)
No
Does the CHA2DS2-VASc score predict long-term major cardiovascular events in patients undergoing elective coronary artery bypass grafting?
Hazard Ratio: 1.615 (95% CI 1.038–2.511)
p-value: p=0.034
A CHA2DS2-VASc score ≥4 is an independent predictor of long-term major cardiovascular events following elective coronary artery bypass grafting, suggesting its utility for risk stratification in this population.
Background: This study aims to investigate the value of the CHA2DS2-VASc score in predicting long-term major cardiovascular events following coronary artery bypass grafting. Methods: Between January 2008 and January 2010, a total of 559 patients (445 males, 114 females; mean age: 62.7±9.1 years; range, 35 to 84 years) who underwent elective coronary artery bypass grafting were retrospectively analyzed. At a mean of 10.7±3.1-year follow-up, major cardiovascular events were considered as the primary endpoint. Results: The multivariate Cox hazard analysis identified the CHA 2 DS 2 -VASc score as an independent predictor of major cardiovascular events (hazard ratio: 1.615; 95% confidence interval: 1.038-2.511; p=0.034). The receiver operating characteristic curve analyses revealed that 3.5 was the most optimal cut-off value of the score predicting major cardiovascular events and the patients were divided into two groups accordingly. The Kaplan-Meier analysis demonstrated a significantly higher incidence of major cardiovascular events in proportion to a higher CHA 2 DS 2 -VASc score (p<0.001). Conclusion: CHA 2 DS 2 -VASc score ≥4, which includes many risk factors for cardiovascular events, can be used as an independent predictor of long-term major cardiovascular events after coronary artery bypass grafting.
No takes yet. Share an insight, caveat, or question.
Ercan et al. (2023) conducted a cohort in Coronary artery disease requiring elective coronary artery bypass grafting (n=559). CHA2DS2-VASc score vs. Lower CHA2DS2-VASc score was evaluated on Long-term major cardiovascular events (MACE) (HR 1.615, 95% CI 1.038-2.511, p=0.034). The CHA2DS2-VASc score was identified as an independent predictor of long-term major cardiovascular events following coronary artery bypass grafting (HR 1.615).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: